A BRD4-Targeting Photothermal Agent for Controlled Protein Degradation

Area of Science:

• Biochemistry
• Nanotechnology
• Oncology

Background:

• BRD4 protein is crucial for cell cycle regulation and differentiation.
• Disrupting BRD4 activity is a promising strategy for cancer therapy.
• Photothermal therapy (PTT) offers potential for cancer treatment.

Purpose of the Study:

• To develop a BRD4-targeting photothermal agent for controlled protein degradation.
• To enhance low-temperature PTT for cancer treatment by specifically targeting BRD4.
• To establish a feasible platform for future PTT agent design.

Main Methods:

• Incorporated a BRD4 inhibitor into a cyanine dye scaffold to create a photothermal agent.
• The agent specifically binds to the bromodomain of BRD4.
• Low power density laser irradiation induced targeted protein degradation.

Main Results:

• The photothermal agent specifically targeted and degraded BRD4 protein upon laser irradiation.
• This targeted degradation destroyed BRD4 structure and inhibited its function.
• The strategy prolonged agent retention in cancer cells and confined degradation to tumor tissue, minimizing side effects.

Conclusions:

• A novel BRD4-targeting photothermal agent was successfully developed.
• This agent enables controlled protein degradation for enhanced low-temperature PTT.
• The platform offers a feasible approach for clinical cancer treatment design.